Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia

Osami Kawarada; Koji Hozawa; Kan Zen; Hsuan Li Huang; Su Hong Kim; Donghoon Choi; Kihyuk Park; Kenichi Kato; Taku Kato; Yoshinori Tsubakimoto; Shigeo Ichihashi; Naoki Fujimura; Akihiro Higashimori; Tomoyasu Sato; Bryan Ping Yen Yan; Skyi Yin Chun Pang; Chumpol Wongwanit; Yew Pung Leong; Benjamin Chua; Robbie K. George; I. Chih Chen; Jen Kuang Lee; Chung Ho Hsu; Uei Pua; Yo Iwata; Kojiro Miki; Kozo Okada; Hideaki Obara

doi:10.1007/s12928-019-00602-z

Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia

Osami Kawarada, Koji Hozawa, Kan Zen, Hsuan Li Huang, Su Hong Kim, Donghoon Choi, Kihyuk Park, Kenichi Kato, Taku Kato, Yoshinori Tsubakimoto, Shigeo Ichihashi, Naoki Fujimura, Akihiro Higashimori, Tomoyasu Sato, Bryan Ping Yen Yan, Skyi Yin Chun Pang, Chumpol Wongwanit, Yew Pung Leong, Benjamin Chua, Robbie K. GeorgeI. Chih Chen, Jen Kuang Lee, Chung Ho Hsu, Uei Pua, Yo Iwata, Kojiro Miki, Kozo Okada, Hideaki Obara

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

1 Citation (Scopus)

Abstract

With technological improvements in the endovascular armamentarium, there have been tremendous advances in catheter-based femoropopliteal artery intervention during the last decade. However, standardization of the methodology for assessing outcomes has been underappreciated, and unvalidated peak systolic velocity ratios (PSVRs) of 2.0, 2.4, and 2.5 on duplex ultrasonography have been arbitrarily but routinely used for assessing restenosis. Quantitative vessel analysis (QVA) is a widely accepted method to identify restenosis in a broad spectrum of cardiovascular interventions, and PSVR needs to be validated by QVA. This multidisciplinary review is intended to disseminate the importance of QVA and a validated PSVR based on QVA for binary restenosis in contemporary femoropopliteal intervention.

Original language	English
Pages (from-to)	52-61
Number of pages	10
Journal	Cardiovascular Intervention and Therapeutics
Volume	35
Issue number	1
DOIs	https://doi.org/10.1007/s12928-019-00602-z
Publication status	Published - 2020 Jan 1

Bibliographical note

Funding Information:
This article was supported in part by Endovascular Asia, a nonprofit physician education and research meeting.

Funding Information:
Osami Kawarada reports honorarium for lectures and advisory board fees from Boston Scientific Corporation, honorarium for lectures and research grants from Terumo. Naoki Fujimura reports consulting fee from Cook Medical, Endologix, and W.L. Gore. Bryan P. Yan reports honorarium of lectures from Boston Scientific Corporation, Cook Medical, Medtronic; research grants from Medtronic, Boston Scientific Corporation, and consultancy fee from Medtronic and Cook Medical. Robbie George reports honorariums or speaker fees or travel and/or research support from the following organizations: Boston Scientific, Bard India, Medtronic India, Cook India, and Abbot India.

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s12928-019-00602-z

Fingerprint Dive into the research topics of 'Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia'. Together they form a unique fingerprint.

Cite this

Kawarada, O., Hozawa, K., Zen, K., Huang, H. L., Kim, S. H., Choi, D., Park, K., Kato, K., Kato, T., Tsubakimoto, Y., Ichihashi, S., Fujimura, N., Higashimori, A., Sato, T., Yan, B. P. Y., Pang, S. Y. C., Wongwanit, C., Leong, Y. P., Chua, B., ... Obara, H. (2020). Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia. Cardiovascular Intervention and Therapeutics, 35(1), 52-61. https://doi.org/10.1007/s12928-019-00602-z

Kawarada, Osami ; Hozawa, Koji ; Zen, Kan ; Huang, Hsuan Li ; Kim, Su Hong ; Choi, Donghoon ; Park, Kihyuk ; Kato, Kenichi ; Kato, Taku ; Tsubakimoto, Yoshinori ; Ichihashi, Shigeo ; Fujimura, Naoki ; Higashimori, Akihiro ; Sato, Tomoyasu ; Yan, Bryan Ping Yen ; Pang, Skyi Yin Chun ; Wongwanit, Chumpol ; Leong, Yew Pung ; Chua, Benjamin ; George, Robbie K. ; Chen, I. Chih ; Lee, Jen Kuang ; Hsu, Chung Ho ; Pua, Uei ; Iwata, Yo ; Miki, Kojiro ; Okada, Kozo ; Obara, Hideaki. / Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention : a multidisciplinary review from Endovascular Asia. In: Cardiovascular Intervention and Therapeutics. 2020 ; Vol. 35, No. 1. pp. 52-61.

@article{78c4c5bc930446efbc2978acc21a76ed,

title = "Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia",

abstract = "With technological improvements in the endovascular armamentarium, there have been tremendous advances in catheter-based femoropopliteal artery intervention during the last decade. However, standardization of the methodology for assessing outcomes has been underappreciated, and unvalidated peak systolic velocity ratios (PSVRs) of 2.0, 2.4, and 2.5 on duplex ultrasonography have been arbitrarily but routinely used for assessing restenosis. Quantitative vessel analysis (QVA) is a widely accepted method to identify restenosis in a broad spectrum of cardiovascular interventions, and PSVR needs to be validated by QVA. This multidisciplinary review is intended to disseminate the importance of QVA and a validated PSVR based on QVA for binary restenosis in contemporary femoropopliteal intervention.",

author = "Osami Kawarada and Koji Hozawa and Kan Zen and Huang, {Hsuan Li} and Kim, {Su Hong} and Donghoon Choi and Kihyuk Park and Kenichi Kato and Taku Kato and Yoshinori Tsubakimoto and Shigeo Ichihashi and Naoki Fujimura and Akihiro Higashimori and Tomoyasu Sato and Yan, {Bryan Ping Yen} and Pang, {Skyi Yin Chun} and Chumpol Wongwanit and Leong, {Yew Pung} and Benjamin Chua and George, {Robbie K.} and Chen, {I. Chih} and Lee, {Jen Kuang} and Hsu, {Chung Ho} and Uei Pua and Yo Iwata and Kojiro Miki and Kozo Okada and Hideaki Obara",

note = "Funding Information: This article was supported in part by Endovascular Asia, a nonprofit physician education and research meeting. Funding Information: Osami Kawarada reports honorarium for lectures and advisory board fees from Boston Scientific Corporation, honorarium for lectures and research grants from Terumo. Naoki Fujimura reports consulting fee from Cook Medical, Endologix, and W.L. Gore. Bryan P. Yan reports honorarium of lectures from Boston Scientific Corporation, Cook Medical, Medtronic; research grants from Medtronic, Boston Scientific Corporation, and consultancy fee from Medtronic and Cook Medical. Robbie George reports honorariums or speaker fees or travel and/or research support from the following organizations: Boston Scientific, Bard India, Medtronic India, Cook India, and Abbot India. ",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/s12928-019-00602-z",

language = "English",

volume = "35",

pages = "52--61",

journal = "Cardiovascular Intervention and Therapeutics",

issn = "1868-4300",

publisher = "Springer Verlag",

number = "1",

}

Kawarada, O, Hozawa, K, Zen, K, Huang, HL, Kim, SH, Choi, D, Park, K, Kato, K, Kato, T, Tsubakimoto, Y, Ichihashi, S, Fujimura, N, Higashimori, A, Sato, T, Yan, BPY, Pang, SYC, Wongwanit, C, Leong, YP, Chua, B, George, RK, Chen, IC, Lee, JK, Hsu, CH, Pua, U, Iwata, Y, Miki, K, Okada, K & Obara, H 2020, 'Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia', Cardiovascular Intervention and Therapeutics, vol. 35, no. 1, pp. 52-61. https://doi.org/10.1007/s12928-019-00602-z

Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention : a multidisciplinary review from Endovascular Asia. / Kawarada, Osami; Hozawa, Koji; Zen, Kan; Huang, Hsuan Li; Kim, Su Hong; Choi, Donghoon; Park, Kihyuk; Kato, Kenichi; Kato, Taku; Tsubakimoto, Yoshinori; Ichihashi, Shigeo; Fujimura, Naoki; Higashimori, Akihiro; Sato, Tomoyasu; Yan, Bryan Ping Yen; Pang, Skyi Yin Chun; Wongwanit, Chumpol; Leong, Yew Pung; Chua, Benjamin; George, Robbie K.; Chen, I. Chih; Lee, Jen Kuang; Hsu, Chung Ho; Pua, Uei; Iwata, Yo; Miki, Kojiro; Okada, Kozo; Obara, Hideaki.

In: Cardiovascular Intervention and Therapeutics, Vol. 35, No. 1, 01.01.2020, p. 52-61.

Research output: Contribution to journal › Review article › peer-review

TY - JOUR

T1 - Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention

T2 - a multidisciplinary review from Endovascular Asia

AU - Kawarada, Osami

AU - Hozawa, Koji

AU - Zen, Kan

AU - Huang, Hsuan Li

AU - Kim, Su Hong

AU - Choi, Donghoon

AU - Park, Kihyuk

AU - Kato, Kenichi

AU - Kato, Taku

AU - Tsubakimoto, Yoshinori

AU - Ichihashi, Shigeo

AU - Fujimura, Naoki

AU - Higashimori, Akihiro

AU - Sato, Tomoyasu

AU - Yan, Bryan Ping Yen

AU - Pang, Skyi Yin Chun

AU - Wongwanit, Chumpol

AU - Leong, Yew Pung

AU - Chua, Benjamin

AU - George, Robbie K.

AU - Chen, I. Chih

AU - Lee, Jen Kuang

AU - Hsu, Chung Ho

AU - Pua, Uei

AU - Iwata, Yo

AU - Miki, Kojiro

AU - Okada, Kozo

AU - Obara, Hideaki

N1 - Funding Information: This article was supported in part by Endovascular Asia, a nonprofit physician education and research meeting. Funding Information: Osami Kawarada reports honorarium for lectures and advisory board fees from Boston Scientific Corporation, honorarium for lectures and research grants from Terumo. Naoki Fujimura reports consulting fee from Cook Medical, Endologix, and W.L. Gore. Bryan P. Yan reports honorarium of lectures from Boston Scientific Corporation, Cook Medical, Medtronic; research grants from Medtronic, Boston Scientific Corporation, and consultancy fee from Medtronic and Cook Medical. Robbie George reports honorariums or speaker fees or travel and/or research support from the following organizations: Boston Scientific, Bard India, Medtronic India, Cook India, and Abbot India.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - With technological improvements in the endovascular armamentarium, there have been tremendous advances in catheter-based femoropopliteal artery intervention during the last decade. However, standardization of the methodology for assessing outcomes has been underappreciated, and unvalidated peak systolic velocity ratios (PSVRs) of 2.0, 2.4, and 2.5 on duplex ultrasonography have been arbitrarily but routinely used for assessing restenosis. Quantitative vessel analysis (QVA) is a widely accepted method to identify restenosis in a broad spectrum of cardiovascular interventions, and PSVR needs to be validated by QVA. This multidisciplinary review is intended to disseminate the importance of QVA and a validated PSVR based on QVA for binary restenosis in contemporary femoropopliteal intervention.

AB - With technological improvements in the endovascular armamentarium, there have been tremendous advances in catheter-based femoropopliteal artery intervention during the last decade. However, standardization of the methodology for assessing outcomes has been underappreciated, and unvalidated peak systolic velocity ratios (PSVRs) of 2.0, 2.4, and 2.5 on duplex ultrasonography have been arbitrarily but routinely used for assessing restenosis. Quantitative vessel analysis (QVA) is a widely accepted method to identify restenosis in a broad spectrum of cardiovascular interventions, and PSVR needs to be validated by QVA. This multidisciplinary review is intended to disseminate the importance of QVA and a validated PSVR based on QVA for binary restenosis in contemporary femoropopliteal intervention.

UR - http://www.scopus.com/inward/record.url?scp=85068843680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068843680&partnerID=8YFLogxK

U2 - 10.1007/s12928-019-00602-z

DO - 10.1007/s12928-019-00602-z

M3 - Review article

C2 - 31292931

AN - SCOPUS:85068843680

VL - 35

SP - 52

EP - 61

JO - Cardiovascular Intervention and Therapeutics

JF - Cardiovascular Intervention and Therapeutics

SN - 1868-4300

IS - 1

ER -